General
EU approves COVID-19 drug Remdesivir
The European Commission has authorized the use of anti-viral drug remdesivir to treat severe cases of COVID-19.
The announcement was made on Friday, July 3, days after the US effectively stockpiled the world’s entire supply of the antiviral medication. Its approval came after two major US studies showed that remdesivir can reduce the duration of hospital stay for COVID-19 patients.
EU Health Commissioner Stella Kyriakides said in a statement;
“Today’s authorisation of a first medicine to treat COVID-19 is an important step forward in the fight against this virus.
“We are granting this authorisation less than a month after the application was submitted, showing clearly the EU’s determination to respond quickly whenever new treatments become available.”
Remdesivir which is the only anti-coronavirus medication to be given the green light in the EU was originally intended as a treatment for Ebola.
The green light comes on the recommendation of the European Medicines Agency which gave its conditional authorisation last week for the treatment of patients above 12 years of age who are suffering pneumonia and require extra oxygen.
It said its assessment was based mainly based on data from a study sponsored by the US National Institute of Allergy and Infectious Diseases (NIAID).
-
Metro23 hours ago
EFCC move against schools charging in dollars
-
Economy23 hours ago
FG to increase mining license fees, charges
-
Entertainment23 hours ago
Nollywood legends Yinka Quadri, Ogogo end long-standing beef
-
Politics18 hours ago
Court stops arrest of APC members behind Ganduje suspension
-
News19 hours ago
Over 30 killed as hydroelectric dam collapse in Brazil
-
News16 hours ago
OPAY bans customers from trading cryptocurrency, virtual trading
-
Entertainment12 hours ago
Nigerian-American singer Shaboozey displaces Beyoncé on Billboard chart
-
News18 hours ago
2024 WPD: Ministers, governors raise awareness on media freedom